b.jansen
TL2 · Faro
Contributes reviews on supplier material. Based in Faro.
Joined 13 May 2025 · last posted 20h
72 posts, newest first. Showing up to 150.
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #52 · Documentation › Doc review · 27 Jul 2026 · 26 likes Source for the draft on reconstitution arithmetic figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating…
-
Review: an evidence digest and the citation check that delayed it Replied, post #18 · Documentation › Doc review · 26 Jul 2026 · 17 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Submitting a sample: the process end to end Replied, post #110 · Sourcing › Independent verification · 25 Jul 2026 · 0 likes The arithmetic on submitting a sample is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
Tracking a shortage from primary sources rather than rumour Replied, post #118 · Access › Shortages · 23 Jul 2026 · 5 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #66 · Practice › Side effects · 22 Jul 2026 · 23 likes Where I part company with post #64, and it is a narrow parting. Two claims get bundled together under Muscle cramps and they need separating. The descriptive one — this…
-
Impurity thresholds: where the common numbers come from Replied, post #6 · Analytics › Impurities & related substances · 16 Jul 2026 · 6 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Restarting after a long gap: what the labelling implies Replied, post #25 · Practice › Dosing & titration · 14 Jul 2026 · 7 likes Understood, and I withdraw the assumption I opened with.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #26 · Access › Insurance & coverage · 14 Jul 2026 · 24 likes An honest declaration on Prior authorisation: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #49 · Analytics › Home & field testing · 12 Jul 2026 · 18 likes A control sample of known material run alongside is what turns a home test from an impression into a comparison. Without one you are calibrating against memory. I would…
-
Coming back to: Time to steady state after a dose increase Replied, post #95 · Pharmacology › Pharmacokinetics · 7 Jul 2026 · 22 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability. That is a description of…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #63 · Access › International · 7 Jul 2026 · 9 likes I read post #61 twice before replying, because I had assumed the opposite. Where a compound is approved under a different trade name in another market, searching the…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #13 · Analytics › Home & field testing · 29 Jun 2026 · 0 likes Post #9 describes the usual case. This is about the unusual one. Cost versus information has been discussed here with more heat than it deserves, mostly because two…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #86 · Devices › Syringes & needles · 27 Jun 2026 · 20 likes Reading the barrel at eye level matters more than any equipment choice. Parallax at a shallow angle is enough to shift a reading by a graduation.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #10 · Practice › Dosing & titration · 22 Jun 2026 · 21 likes Coming back to post #6, because the follow-up matters more than the original answer. Concentration and dose get conflated constantly in this subcategory. Changing how…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #27 · Access › Pricing · 1 Jun 2026 · 10 likes I read post #23 twice before replying, because I had assumed the opposite. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance…
-
A 40-week log with the measurement method stated — what changed since Replied, post #6 · Outcomes › Progress reports · 1 Jun 2026 · 0 likes Narrowing post #5, because the general version has more than one answer. Seasonal patterns: some people report weight loss is slower in winter than summer. Body…
-
Five questions in one post gets you one answer — how to split them Replied, post #87 · Start Here › How to Ask · 21 May 2026 · 26 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #29 · Compounds › Semaglutide · 16 May 2026 · 33 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
-
Journal club: LEADER as the historical anchor Replied, post #72 · Evidence › Journal club · 10 May 2026 · 0 likes LEADER came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #9 · Research Methods › N-of-1 designs · 22 Apr 2026 · 20 likes It does not tell you about anybody else, which is why aggregating these accounts does not produce evidence of the kind people want it to. I have deliberately not…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #40 · Practice › Reconstitution · 20 Apr 2026 · 2 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
The "under review" status pill and when a moderator applies it Replied, post #69 · Evidence › Preprints · 12 Apr 2026 · 3 likes Confirming post #66 from a second method, which matters more than confirming it from a second person. The honest position on most preprints in this field is that they…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #55 · Data & Tools › Calculators · 9 Apr 2026 · 27 likes A saved calculation is worth more than a remembered one. Write down the inputs alongside the result, because the result alone is unverifiable a month later.
-
Spike-and-recover accuracy for a peptide assay Replied, post #54 · Analytics › Method validation · 8 Apr 2026 · 0 likes Two questions I would want answered before drawing anything from the spike-and-recover accuracy data above: how were the cases selected, and what happened to the ones…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #52 · Analytics › Mass spectrometry · 3 Apr 2026 · 29 likes This follows post #51 rather than contradicting it. What I want from this Charge states thread is the list of things that would need to be true for the claim to hold.…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #37 · Data & Tools › Datasets · 13 Mar 2026 · 7 likes Worth separating two things that post #35 runs together. Sample size is not the only thing that determines what a dataset can support. Selection is usually the larger…
-
The lowest dose that does anything: is that a real question? Replied, post #96 · Practice › Dosing & titration · 7 Mar 2026 · 20 likes This follows post #95 rather than contradicting it. Half steps are arithmetically simple and pharmacologically unstudied. They are not dangerous in any obvious way and…
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 3 Mar 2026 · 5 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #2 · Analytics › Impurities & related substances · 19 Feb 2026 · 0 likes The opening post put the caveat in the right place and I want to underline it. Deamidation at asparagine or glutamine adds approximately one dalton and frequently…
-
Coming back to: Training through a dose escalation week Replied, post #23 · Nutrition & Training › Resistance training · 6 Feb 2026 · 14 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
[2026 update] What a purity-only report leaves out Replied, post #14 · Sourcing › Independent verification · 2 Feb 2026 · 32 likes Where I part company with post #10, and it is a narrow parting. The record shows what was measured. Everything beyond that is inference and this site tries to keep the…
-
Reused chromatograms across lots: how to spot it Replied, post #16 · Analytics › COA interpretation · 25 Jan 2026 · 6 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #23 · Clinical › Special populations · 25 Jan 2026 · 7 likes Adding the measurement that post #22 says would settle it. Post-surgical populations, particularly after procedures affecting the gastrointestinal tract, interact with…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #14 · Sourcing › Logistics · 29 Dec 2025 · 4 likes Confirming post #13 from a second method, which matters more than confirming it from a second person. Peak periods and public holidays affect this more than any other…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Started this topic · Outcomes › Body composition · 11 Dec 2025 · 42 likes Posting this under the heading it deserves: Ultrasound and skinfolds: operator dependence in practice — what changed since Everything below is what sits behind that.…
-
Liver enzymes drifting down and what that usually means Replied, post #25 · Clinical › Bloodwork · 6 Nov 2025 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #87 · Analytics › Home & field testing · 31 Oct 2025 · 9 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #70 · Analytics › HPLC & UHPLC · 25 Oct 2025 · 0 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #109 · Lounge › Off topic · 20 Oct 2025 · 12 likes Lounge question, no agenda: does anyone else keep a physical notebook for this rather than a file? Mine is more use than anything I have typed, and I cannot entirely…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #29 · Data & Tools › Datasets · 5 Oct 2025 · 7 likes Where a dataset is used to support a claim in a maintained document, the version used should be cited. Otherwise the document and the data drift apart silently.
-
Compounds this community declines to help with, and why Replied, post #32 · Compounds › Other compounds · 29 Sep 2025 · 8 likes Fragment compounds — where the material is part of a larger natural protein — should be identified by sequence rather than by name, because the naming in this space is…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #61 · Lounge › Off topic · 27 Sep 2025 · 30 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. The literature is thinner on this than the confidence in the thread…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #25 · Evidence › Study critique · 13 Sep 2025 · 0 likes Reverse causation is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #15 · Compounds › Tirzepatide · 8 Sep 2025 · 28 likes Coming back to post #11, because the follow-up matters more than the original answer. Research-use-only tirzepatide is not approved for human use and is not made to…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #108 · Practice › Reconstitution · 18 Aug 2025 · 0 likes Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more…
-
Coming back to: Why the cheapest option is often not the cheapest Replied, post #24 · Access › Pricing · 17 Jun 2025 · 0 likes Worth separating two things that post #20 runs together. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is…
-
Insulin combinations and hypoglycaemia risk Replied, post #10 · Practice › Interactions · 16 Jun 2025 · 2 likes Everything in post #8 holds. The case it does not cover is the one I have. Reporting rather than recommending, on insulin combinations and hypoglycaemia risk. What…
-
Coming back to: Getting a referral rather than a refusal Replied, post #61 · Clinical › Prescriber conversations · 12 Jun 2025 · 4 likes Thank you for taking the time. That was more work than a reply usually is.
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #55 · Nutrition & Training › Protein & intake · 10 Jun 2025 · 7 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
[2026 update] US compounding rules and how they changed Replied, post #16 · Regional › North America · 30 May 2025 · 0 likes Post #12 put the caveat in the right place and I want to underline it. Appeals succeed more often than people expect when they answer the stated criterion point by…
-
Lipase elevation without symptoms: the interpretation problem — a second dataset Replied, post #2 · Clinical › Bloodwork · 19 May 2025 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. TSH and free hormones: TSH is a reasonable screening test but does not tell you…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #24 · Evidence › Trials · 11 May 2025 · 13 likes I read post #22 twice before replying, because I had assumed the opposite. Second-hand on Sample size calculations, so weight it accordingly — someone whose method I…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #62 · Evidence › Journal club · 27 Apr 2025 · 26 likes Post #61 is the version of this I will quote in future. One addition. Reframing STEP 4 slightly, because I think the disagreement is about the question rather than the…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #7 · Evidence › Journal club · 25 Mar 2025 · 3 likes Confirming post #4 from a second method, which matters more than confirming it from a second person. The baseline characteristics table is the single most useful page…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #22 · Compounds › Retatrutide · 6 Mar 2025 · 3 likes Coming back to post #20, because the follow-up matters more than the original answer. Triple agonism is well covered in the tag pages, and the older discussions are…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #27 · Clinical › Comorbidities · 6 Mar 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Pharmaceutical compounding rules, summarised from primary sources Started this topic · Sourcing › Regulatory · 26 Feb 2025 · 0 likes Pharmaceutical compounding rules, summarised from primary sources — setting out what I have, and where I think it stops being reliable. Asking what a regulator's…
-
Contributing data without breaching anyone's privacy — what changed since Replied, post #3 · Data & Tools › Datasets · 15 Feb 2025 · 13 likes Taking post #2 at face value and following it one step further. Include the denominator. A collection of reports without knowing how many people did not report is…
-
When "no data" is the complete and final answer Replied, post #91 · Compounds › Other compounds · 13 Feb 2025 · 1 like Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #26 · Sourcing › Vendor reports · 25 Jan 2025 · 4 likes Where you have no independent result, a documentation report is still worth filing: what the certificate contained, what it omitted, and how fast a request was…
-
Body image changing more slowly than the body Replied, post #107 · Wellbeing › Mental health · 23 Dec 2024 · 6 likes The social side of this — how other people respond to visible change — comes up constantly and has nothing to do with pharmacology. If that is already documented…
-
Fixed versus detachable needles: the trade-offs Replied, post #42 · Devices › Syringes & needles · 10 Dec 2024 · 12 likes Offering a way to settle fixed versus detachable needles rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #46 · Nutrition & Training › Protein & intake · 9 Dec 2024 · 0 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help.
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #2 · Sourcing › Vendor reports · 27 Oct 2024 · 18 likes The opening post put the caveat in the right place and I want to underline it. Blind submission is worth the extra effort. Have someone else relabel the sample so…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #34 · Compounds › Tirzepatide · 14 Oct 2024 · 21 likes Coming back to post #32, because the follow-up matters more than the original answer. If you are new and reading this thread for the answer to SURPASS-2: the answer is…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #124 · Access › Shortages · 13 Oct 2024 · 27 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated. Worth checking against a second…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #99 · Clinical › Bloodwork · 11 Oct 2024 · 1 like Bring a laboratory is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #53 · Access › Shortages · 11 Oct 2024 · 1 like Planning around a known shortage window is easier than reacting to one, and the notices give advance warning more often than people expect.
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #9 · Compounds › Oral incretins · 26 Aug 2024 · 24 likes Picking up post #7: that is the part I would want checked first. Adding what did not work for me on orforglipron, since the failures never get written up and they are…
-
Circumference measurements as a poor man's composition estimate Replied, post #76 · Outcomes › Body composition · 18 Aug 2024 · 30 likes Post #75 is the version of this I will quote in future. One addition. Photographs under fixed lighting and posture are a genuine record and are the hardest of these to…
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #22 · Safety › Contraindications · 21 Jul 2024 · 0 likes Personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia type 2, is the clearest contraindication in this class and it is specific…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #17 · Practice › Interactions · 8 Jul 2024 · 0 likes Posting my oral contraceptives and delayed emptying numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by…